Skip to main content
. 2015 May 20;4(8):1186–1195. doi: 10.1002/cam4.469

Figure 1.

Figure 1

Study design of alternating chemoradiotherapy. 5FU: 5-fluorouracil; 800 mg/m2 per day i.v. continuous infusion × 5 days (day 1–5); CDDP: cisplatin, 100 mg/m2 per day i.v. continuous infusion (day 6); Field A: large field (from the skull base to the supraclavicular fossa), 1.8 Gy/f, 5 f/w, total tumor dose; 36 Gy; Field B: shrinking field, 2 Gy/f, 5 f/w, total tumor dose; 34 Gy. The interval between Field A and Field B is 10–12 days.